𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer

✍ Scribed by Huang, Cheng-long; Taki, Toshihiko; Adachi, Masashi; Konishi, Takaaki; Higashiyama, Masahiko; Miyake, Masayuki


Book ID
110061296
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
357 KB
Volume
16
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Analysis of p53 mutations in histologica
✍ Weimin Gao; Hussam H. Mady; Mona F. Melhem; Phouthone Keohavong πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 163 KB

## Abstract Our previous study showed a characteristic p53 mutational spectrum in lung tumors from lung cancer patients in the Western Pennsylvania region. To further understand the involvement of p53 mutations in lung tumor development, in this study we compared p53 mutational spectra and distribu

Prognostic significance of serum p53 ant
✍ GΓ©rard Zalcman; Jean TrΓ©daniel; Beata Schlichtholz; Thierry Urban; Bernard Mille πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 239 KB πŸ‘ 2 views

p53 tumour suppressor gene alterations are one of the most frequent genetic events in lung cancer. A subset of patients with p53 mutation and cancer exhibited circulating serum anti-p53 self-antibodies (p53-Ab). The prevalence of these antibodies in lung cancer is currently being analysed in a multi

Quantitative analysis of p53 protein in
✍ Michael A. Levesque; Mario D'Costa; Ernest H. Spratt; Mohammad M. Yaman; Elefthe πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 99 KB πŸ‘ 2 views

Accumulation of mutant p53 protein occurs frequently in human malignancies, including 40-60% of non-small cell lung carcinomas. The implications of such p53 over-expression, usually assessed by immunohistochemical techniques, for the prognosis of lung cancer patients remain undetermined. In this stu